(Q46855528)

25 December 2017

title

Flecainide for the treatment of chronic neuropathic pain: a Phase II trial (English)

1 reference

25 December 2017

main subject

neuropathic pain

0 references

phase II clinical trial

0 references

chronic pain

0 references

chronic neuropathic pain

0 references

8

David Cella

1 reference

25 December 2017

7

Charles Cleeland

1 reference

25 December 2017

author name string

Charles F von Gunten

1

1 reference

25 December 2017

Sarah Eappen

2

1 reference

25 December 2017

James Francis Cleary

3

1 reference

25 December 2017

Samuel G Taylor

4

1 reference

25 December 2017

Paul Moots

5

1 reference

25 December 2017

Nina Regevik

6

1 reference

25 December 2017

publication date

1 December 2007

1 reference

25 December 2017

published in

Palliative Medicine

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

8

1 reference

25 December 2017

page(s)

667-672

1 reference

25 December 2017

Ensuring competency in end-of-life care: controlling symptoms

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

The principles of cancer pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Management of intractable pain in adiposis dolorosa with intravenous administration of lidocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Parenteral lidocaine for severe intractable pain in six hospice patients continued at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216307083031

21 January 2018

Identifiers

DOI

10.1177/0269216307083031

1 reference

25 December 2017

1 reference

25 December 2017